(Q39708856)

14 September 2017

1 reference

title

Thalassaemia. (English)

1 reference

14 September 2017

Douglas R Higgs

1

0 references

author name string

James Douglas Engel

series ordinal

2

1 reference

14 September 2017

George Stamatoyannopoulos

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

9 September 2011

1 reference

14 September 2017

1 reference

14 September 2017

volume

379

1 reference

14 September 2017

issue

9813

1 reference

14 September 2017

page(s)

373-383

1 reference

The inherited diseases of hemoglobin are an emerging global health burden

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

1 reference

7 January 2021

Towards molecular medicine; reminiscences of the haemoglobin field, 1960-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Locus control regions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Beta-globin regulation and long-range interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Long-range regulation of alpha globin gene expression during erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Ontogeny of erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Fine tuning of globin gene expression by DNA methylation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Epigenetics of beta-globin gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Intergenic transcription, cell-cycle and the developmentally regulated epigenetic profile of the human beta-globin locus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

The language of covalent histone modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Three-dimensional organization of gene expression in erythroid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Transcriptional regulation of erythropoiesis: an affair involving multiple partners

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Advances in the understanding of haemoglobin switching

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Control of globin gene expression during development and erythroid differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Insulators: exploiting transcriptional and epigenetic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Screening and genetic diagnosis of haemoglobin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

The hemoglobin E syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Gamma delta beta-thalassemia due to a de novo mutation deleting the 5' beta-globin gene activation-region hypersensitive sites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

β-Globin gene inactivation by DNA translocation in γβ-thalassaemi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Molecular basis of hereditary persistence of fetal hemoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

GATA transcription factors in hematologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

KLF1 regulates BCL11A expression and γ- to β-globin gene switching

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Control of fetal hemoglobin: new insights emerging from genomics and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Hepcidin and Hfe in iron overload in beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Controlling alpha-globin: a review of alpha-globin expression and its impact on beta-thalassemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Global epidemiology of haemoglobin disorders and derived service indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

The population genetics and dynamics of the thalassemias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Reproductive behavior and health in consanguineous marriages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

1 reference

7 January 2021

Studies in haemoglobin E beta-thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Thalassaemia: clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Survival in medically treated patients with homozygous beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Deferasirox--current knowledge and future challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Optimal management of β thalassaemia intermedia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Noninvasive approaches to prenatal diagnosis of hemoglobinopathies using fetal DNA in maternal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Screening for thalassemia: a model of success.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Genetic modifiers of the beta-haemoglobinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Haemoglobin F modulation in childhood sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Hematopoietic cell transplantation for hemoglobinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Bone marrow transplantation for beta-thalassaemia major: the UK experience in two paediatric centres.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Bone marrow transplantation in patients with thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Gene therapy for β-thalassaemia: the continuing challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Advances in the allogeneic transplantation for thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Cord blood transplantation in patients with hemoglobinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Gene therapy for human genetic disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Efficacy of gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Update on gene therapy for immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Gene therapy. Beta-thalassemia treatment succeeds, with a caveat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Induced pluripotent stem cell lines derived from human somatic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

A New Dawn for Stem-Cell Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960283-3

7 January 2021

10.1016/S0140-6736(11)60283-3

Identifiers

DOI

1 reference

release_3hm7e5ntwrfape6tyimufjyjci

14 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3hm7e5ntwrfape6tyimufjyjci

24 November 2022

mapped directly with Wikidata item

1 reference